- Home
- UUUU vs SUPN Comparison
UUUU vs SUPN Comparison
Compare UUUU & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UUUU
- SUPN
- Stock Information
- Founded
- UUUU 1987
- SUPN 2005
- Country
- UUUU United States
- SUPN United States
- Employees
- UUUU N/A
- SUPN N/A
- Industry
- UUUU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- SUPN Biotechnology: Pharmaceutical Preparations
- Sector
- UUUU Industrials
- SUPN Health Care
- Exchange
- UUUU Nasdaq
- SUPN Nasdaq
- Market Cap
- UUUU 2.7B
- SUPN 2.6B
- IPO Year
- UUUU N/A
- SUPN 2012
- Fundamental
- Price
- UUUU $11.95
- SUPN $45.46
- Analyst Decision
- UUUU Strong Buy
- SUPN Buy
- Analyst Count
- UUUU 4
- SUPN 2
- Target Price
- UUUU $9.31
- SUPN $43.00
- AVG Volume (30 Days)
- UUUU 14.8M
- SUPN 638.4K
- Earning Date
- UUUU 10-30-2025
- SUPN 11-03-2025
- Dividend Yield
- UUUU N/A
- SUPN N/A
- EPS Growth
- UUUU N/A
- SUPN 1411.53
- EPS
- UUUU N/A
- SUPN 1.14
- Revenue
- UUUU $65,078,999.00
- SUPN $665,125,000.00
- Revenue This Year
- UUUU N/A
- SUPN $4.84
- Revenue Next Year
- UUUU $174.83
- SUPN $17.69
- P/E Ratio
- UUUU N/A
- SUPN $40.79
- Revenue Growth
- UUUU 42.73
- SUPN 5.55
- 52 Week Low
- UUUU $3.20
- SUPN $29.16
- 52 Week High
- UUUU $13.46
- SUPN $46.79
- Technical
- Relative Strength Index (RSI)
- UUUU 58.91
- SUPN 64.24
- Support Level
- UUUU $10.94
- SUPN $45.26
- Resistance Level
- UUUU $13.46
- SUPN $46.72
- Average True Range (ATR)
- UUUU 0.87
- SUPN 1.04
- MACD
- UUUU 0.03
- SUPN -0.24
- Stochastic Oscillator
- UUUU 48.33
- SUPN 55.96
About UUUU Energy Fuels Inc (Canada)
Energy Fuels Inc is a United States-based critical minerals company. The Company mines uranium and produces natural uranium concentrates that are sold to nuclear utilities for the production of carbon-free nuclear energy. It holds two of America's key uranium production centers: The White Mesa Mill in Utah, and the Nichols Ranch ISR Facility in Wyoming. It has three reportable segments based on its operations and financial information; Uranium, HMS, and REE.
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.